Rallybio Corp (NASDAQ: RLYB) kicked off on Friday, down -4.01% from the previous trading day, before settling in for the closing price of $0.79. Over the past 52 weeks, RLYB has traded in a range of $0.73-$3.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 22.83%. With a float of $20.39 million, this company’s outstanding shares have now reached $41.49 million.
The firm has a total of 43 workers. Let’s measure their productivity. In terms of profitability, gross margin is 87.29%, operating margin of -8474.58%, and the pretax margin is -7892.01%.
Rallybio Corp (RLYB) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rallybio Corp is 50.86%, while institutional ownership is 29.60%.
Rallybio Corp (RLYB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -14.06% during the next five years compared to -35.52% drop over the previous five years of trading.
Rallybio Corp (NASDAQ: RLYB) Trading Performance Indicators
Take a look at Rallybio Corp’s (RLYB) current performance indicators. Last quarter, stock had a quick ratio of 9.55. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 52.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.59, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.32 in one year’s time.
Technical Analysis of Rallybio Corp (RLYB)
Analysing the last 5-days average volume posted by the [Rallybio Corp, RLYB], we can find that recorded value of 0.1 million was better than the volume posted last year of 64827.0. As of the previous 9 days, the stock’s Stochastic %D was 15.55%. Additionally, its Average True Range was 0.06.
During the past 100 days, Rallybio Corp’s (RLYB) raw stochastic average was set at 5.53%, which indicates a significant decrease from 12.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.44% in the past 14 days, which was higher than the 53.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9390, while its 200-day Moving Average is $1.1983. Now, the first resistance to watch is $0.7864. This is followed by the second major resistance level at $0.8192. The third major resistance level sits at $0.8394. If the price goes on to break the first support level at $0.7334, it is likely to go to the next support level at $0.7132. Should the price break the second support level, the third support level stands at $0.6804.
Rallybio Corp (NASDAQ: RLYB) Key Stats
The company with the Market Capitalisation of 31.26 million has total of 41,488K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -74,560 K annual income. Company’s last quarter sales were recorded 300 K and last quarter income was -11,470 K.
